|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/50 | |
| A61P 35/00 | |||
| C12N 9/78 | |||
| A61K 31/34 | |||
| A61K 31/337 |
| (11) | Number of the document | 3052116 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14850304.8 |
| Date of filing the European patent application | 2014-10-03 | |
| (97) | Date of publication of the European application | 2016-08-10 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/059196 |
| Date | 2014-10-03 |
| (87) | Number | WO 2015/051340 |
| Date | 2015-04-09 |
| (30) | Number | Date | Country code |
| 201361887304 P | 2013-10-04 | US |
| (72) |
Ann, David K., US
Chen, Yun-Ru, US
Qiu, Fuming, US
Kung, Hsing-Jien, US
|
| (73) |
Ann, David K.,
536 Walnut Avenue, Arcadia, California 91007,
US
Chen, Yun-Ru, 1500 E. Duarte Road, Duarte, California 91010, US Qiu, Fuming, 1500 East Duarte Road, Duarte, California 91010, US Kung, Hsing-Jien, UCDMC Research III 95 Room 2400B 4645 2nd Avenue, Sacramento, California 95817, US |
| (54) | ARGINASE I, ARGINASE II, OR ADI IN COMBIANTION WITH DOXORUBICIN FOR USE IN A TREATMNT OF A BREAST CANCER |
| ARGINASE I, ARGINASE II, OR ADI IN COMBIANTION WITH DOXORUBICIN FOR USE IN A TREATMNT OF A BREAST CANCER |